Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi


  • Zhihui XieEmail author
  • Kirk M. Druey
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_261


Historical Background

Regulator of G-protein signaling (RGS) is a protein superfamily discovered in the mid-1990s (Druey et al. 1996; Watson et al. 1996; Hunt et al. 1996). Since that time, more than 30 members in the family have been identified. The major physiological function of RGS molecules is to negatively modulate G-protein-coupled receptor (GPCR)-mediated signaling and biology (Bansal et al. 2007; Neitzel and Hepler 2006; Thompson et al. 2008). RGS13 was first identified in 1996 and is one of the smallest molecules in the family (Druey et al. 1996). Full-length human RGS13 cDNA was cloned and deposited into gene bank in 1997 by Chatterjee and Fisher. In 2002, the first functional studies of human RGS13 were reported. RGS13 was shown to inhibit muscarinic M1- and M2 receptor-induced MAP kinase activation (Johnson and Druey 2002). Concurrently, a separate study characterized mouse RGS13, which was cloned from B cells. RGS13...

This is a preview of subscription content, log in to check access.



This study was supported by the Intramural Research Program of the NIH, NIAID.


  1. Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther. 2007;116:473–95.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol. 2008a;9:73–80.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Bansal G, DiVietro JA, Kuehn HS, Rao S, Nocka KH, Gilfillan AM, Druey KM. RGS13 controls G protein-coupled receptor-evoked responses of human mast cells. J Immunol. 2008b;181:7882–90.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Druey KM, Blumer KJ, Kang VH, Kehrl JH. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature. 1996;379:742–6.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell. 2004;119:75–86.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol. 2006;6:218–30.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Grafstein-Dunn E, Young KH, Cockett MI, Khawaja XZ. Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Brain Res Mol Brain Res. 2001;88:113–23.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Han JI, Huang NN, Kim DU, Kehrl JH. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leukoc Biol. 2006;79:1357–68.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2008;9:166–75.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Hunt TW, Fields TA, Casey PJ, Peralta EG. RGS10 is a selective activator of G alpha i GTPase activity. Nature. 1996;383:175–7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Hwang IY, Hwang KS, Park C, Harrison KA, Kehrl JH. RGS13 constrains early B cell responses and limits germinal center sizes. PLoS One. 2013;8:e60139.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Islam TC, Asplund AC, Lindvall JM, Nygren L, Liden J, Kimby E, Christensson B, Smith CI, Sander B. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia. 2003;17:1880–90.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Iwaki S, Lu Y, Xie Z, Druey KM. p53 negatively regulates RGS13 protein expression in immune cells. J Biol Chem. 2011; epublished ahead of print.Google Scholar
  14. Johnson EN, Druey KM. Functional characterization of the G protein regulator RGS13. J Biol Chem. 2002;277:16768–74.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res. 2004;122:24–34.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Neitzel KL, Hepler JR. Cellular mechanisms that determine selective RGS protein regulation of G protein-coupled receptor signaling. Semin Cell Dev Biol. 2006;17:383–9.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Patel TB. Single transmembrane spanning heterotrimeric g protein-coupled receptors and their signaling cascades. Pharmacol Rev. 2004;56:371–85.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O’Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood. 2009;113:4016–26.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Sethakorn N, Dulin N. RGS expression in cancer: oncomining the cancer microarray data. J Recept Signal Transduct Res. 2013;33:166–71.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol. 2002;169:2507–15.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Thompson MD, Cole DE, Jose PA. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease. Methods Mol Biol. 2008;448:77–107.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Wang JH, New JS, Xie S, Yang PA, Wu Q, Li J, Luo B, Ding Y, Druey KM, Hsu HC, Mountz J. Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice. Arthritis Rheum. 2013;65:2703–12.PubMedPubMedCentralGoogle Scholar
  23. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature. 1996;383:172–5.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Xie Z, Geiger TR, Johnson EN, Nyborg JK, Druey KM. RGS13 acts as a nuclear repressor of CREB. Mol Cell. 2008;31:660–70.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Xie Z, Yang Z, Druey KM. Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation. J Mol Cell Biol. 2010;2:357–65.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Molecular and Signal Transduction Section, Laboratory of Allergic DiseasesNational Institute of Allergy and infectious Diseases, National Institutes of HealthBethesdaUSA